1. Home
  2. ALLT vs PBYI Comparison

ALLT vs PBYI Comparison

Compare ALLT & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allot Ltd.

ALLT

Allot Ltd.

HOLD

Current Price

$8.61

Market Cap

364.0M

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$7.12

Market Cap

343.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLT
PBYI
Founded
1996
2010
Country
Israel
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
364.0M
343.9M
IPO Year
2006
2011

Fundamental Metrics

Financial Performance
Metric
ALLT
PBYI
Price
$8.61
$7.12
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$12.40
N/A
AVG Volume (30 Days)
482.0K
260.5K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$27,685,000.00
Revenue This Year
$15.84
N/A
Revenue Next Year
$12.09
N/A
P/E Ratio
$469.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.12
$3.03
52 Week High
$11.92
$7.90

Technical Indicators

Market Signals
Indicator
ALLT
PBYI
Relative Strength Index (RSI) 65.59 45.95
Support Level $8.48 $6.32
Resistance Level $10.60 $7.25
Average True Range (ATR) 0.40 0.25
MACD 0.08 -0.01
Stochastic Oscillator 89.07 50.83

Price Performance

Historical Comparison
ALLT
PBYI

About ALLT Allot Ltd.

Allot Ltd is a provider of security and network intelligence solutions for mobile, fixed, and cloud service providers, as well as enterprises. It offers network-based security solutions such as mobile security, DDoS protection, and IoT security, along with network analytics and traffic management. It focuses on expanding its Security-as-a-Service (SECaaS) offerings through the Allot Secure product family, which delivers unified protection for consumers and SMBs across mobile, fixed, and 5G networks. Its Allot Smart solutions enable service providers to analyze and manage network data, optimize performance, reduce costs, and enhance user experience. It has a customer base in Europe, which generates maximum revenue, as well as in Asia and Oceania, the Americas, the Middle East, and Africa.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: